Brown Advisory’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.07M Sell
53,703
-309
-0.6% -$52.8K 0.01% 431
2025
Q4
$9.12M Sell
54,012
-2,865
-5% -$465K 0.01% 432
2025
Q3
$8.21M Sell
56,877
-3,043
-5% -$415K 0.01% 445
2025
Q2
$7.58M Sell
59,920
-20,590
-26% -$2.53M 0.01% 451
2025
Q1
$10.3M Sell
80,510
-545
-0.7% -$73.9K 0.01% 390
2024
Q4
$10.7M Sell
81,055
-1,750
-2% -$246K 0.01% 413
2024
Q3
$12.1M Sell
82,805
-79
-0.1% -$11.4K 0.02% 394
2024
Q2
$11.4M Buy
82,884
+5,132
+7% +$685K 0.01% 397
2024
Q1
$10.7M Sell
77,752
-16,582
-18% -$2.26M 0.01% 412
2023
Q4
$12.8M Buy
94,334
+17,651
+23% +$2.15M 0.02% 375
2023
Q3
$9.38M Sell
76,683
-2,860
-4% -$364K 0.02% 396
2023
Q2
$10.1M Sell
79,543
-1,136
-1% -$148K 0.02% 400
2023
Q1
$10.4M Sell
80,679
-2,566
-3% -$336K 0.02% 388
2022
Q4
$10.9M Buy
83,245
+7,876
+10% +$1.02M 0.02% 383
2022
Q3
$8.81M Sell
75,369
-15,236
-17% -$1.89M 0.02% 384
2022
Q2
$10.7M Buy
90,605
+28,376
+46% +$3.37M 0.02% 371
2022
Q1
$8.11M Sell
62,229
-5,412
-8% -$705K 0.01% 413
2021
Q4
$10.3M Sell
67,641
-1,174
-2% -$182K 0.01% 391
2021
Q3
$11.1M Buy
68,815
+3,176
+5% +$534K 0.02% 364
2021
Q2
$10.7M Buy
65,639
+2,756
+4% +$425K 0.02% 369
2021
Q1
$9.47M Buy
62,883
+1,267
+2% +$201K 0.02% 361
2020
Q4
$9.34M Sell
61,616
-20,737
-25% -$2.96M 0.02% 354
2020
Q3
$11.2M Buy
82,353
+30,907
+60% +$4.19M 0.02% 300
2020
Q2
$7.03M Buy
51,446
+13,236
+35% +$1.69M 0.02% 355
2020
Q1
$4.12M Sell
38,210
-495
-1% -$57K 0.01% 387
2019
Q4
$4.66M Sell
38,705
-1,120
-3% -$125K 0.01% 418
2019
Q3
$3.96M Buy
39,825
+345
+0.9% +$36.1K 0.01% 431
2019
Q2
$4.31M Sell
39,480
-1,416
-3% -$151K 0.01% 423
2019
Q1
$4.57M Sell
40,896
-70
-0.2% -$7.68K 0.01% 463
2018
Q4
$3.95M Buy
40,966
+570
+1% +$60.5K 0.01% 457
2018
Q3
$4.92M Hold
40,396
0.01% 450
2018
Q2
$4.44M Sell
40,396
-25
-0.1% -$2.67K 0.01% 464
2018
Q1
$4.31M Sell
40,421
-2,727
-6% -$302K 0.01% 415
2017
Q4
$4.61M Buy
43,148
+2,597
+6% +$278K 0.01% 415
2017
Q3
$4.51M Buy
40,551
+450
+1% +$48.1K 0.02% 410
2017
Q2
$4.14M Sell
40,101
-17,889
-31% -$1.76M 0.01% 433
2017
Q1
$5.67M Sell
57,990
-1,245
-2% -$119K 0.02% 357
2016
Q4
$5.24M Buy
59,235
+17,634
+42% +$1.6M 0.02% 368
2016
Q3
$4.01M Sell
41,601
-120
-0.3% -$11.4K 0.01% 398
2016
Q2
$3.58M Hold
41,721
0.01% 405
2016
Q1
$3.63M Sell
41,721
-54
-0.1% -$4.83K 0.01% 397
2015
Q4
$4.71M Hold
41,775
0.02% 373
2015
Q3
$4.22M Buy
41,775
+291
+0.7% +$34.9K 0.02% 381
2015
Q2
$5.1M Sell
41,484
-351
-0.8% -$42K 0.02% 344
2015
Q1
$4.79M Buy
41,835
+291
+0.7% +$32.1K 0.02% 354
2014
Q4
$4.2M Hold
41,544
0.01% 370
2014
Q3
$3.79M Hold
41,544
0.01% 368
2014
Q2
$3.56M Hold
41,544
0.01% 380
2014
Q1
$3.27M Sell
41,544
-477
-1% -$39.7K 0.01% 383
2013
Q4
$3.18M Sell
42,021
-84
-0.2% -$5.96K 0.01% 375
2013
Q3
$2.94M Buy
42,105
+1,131
+3% +$74.1K 0.01% 372
2013
Q2
$2.38M Buy
+40,974
New +$2.37M 0.01% 378

Other funds holding IBB

Brown Advisory's IBB Position: Q1 2026 in Review

Brown Advisory reduced its iShares Biotechnology ETF (IBB) stake by 0.57% in Q1 2026, selling an estimated $52.8K and leaving 53,703 shares worth $9.07M. The position accounts for 0.01% of the portfolio, ranked #431.

Brown Advisory first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.8M in Q4 2023. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Brown Advisory held 53,703 shares of iShares Biotechnology ETF worth $9.07M as of Q1 2026.
  • Brown Advisory sold 309 iShares Biotechnology ETF shares in Q1 2026, an estimated $52.8K.
  • iShares Biotechnology ETF made up 0.01% of Brown Advisory's portfolio in Q1 2026, its #431 holding.
  • Brown Advisory first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
  • Brown Advisory's iShares Biotechnology ETF position peaked at $12.8M in Q4 2023.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.